Investigation into conolidine has resulted in discovery of an opioid receptor in the human body named ACKR3/CXCR7. ACKR3 seems to be by far the most wanted concen
Early research suggests that conolidine may not increase tolerance in clients. Therefore delivering a steady and effective therapy for pain with no want for growi